血友病 发表于 2025-3-27 00:33:00

http://reply.papertrans.cn/1/84/8344/8344-31.png

BUCK 发表于 2025-3-27 04:23:45

http://reply.papertrans.cn/1/84/8344/8344-32.png

Thymus 发表于 2025-3-27 07:12:58

http://reply.papertrans.cn/1/84/8344/8344-33.png

Inkling 发表于 2025-3-27 11:32:12

http://reply.papertrans.cn/1/84/8344/8344-34.png

傲慢物 发表于 2025-3-27 15:04:55

http://reply.papertrans.cn/1/84/8344/8344-35.png

fidelity 发表于 2025-3-27 20:42:20

Submitted on: 24 April 2007.
Revised on: 09 July 2007.
Accepted on: 09 August 2007.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets
页: 1 2 3 [4]
查看完整版本: SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (IMMUN